September 6, 2022
5 virus families that could cause the next pandemic, according to the experts
Learn more about five most concerning virus families that could fuel future pandemics
APPRISE News
August 18, 2022
Engage, understand, listen and act: evaluation of Community Panels to privilege First Nations voices in pandemic planning and response in Australia
How government and policymakers can meaningfully engage First Nations Peoples in decision-making around pandemic response
August 17, 2022
What is this new Langya virus? Do we need to be worried?
Little is known about how severe the infection can be, how it spreads, and how widespread it might be
July 27, 2022
By June, almost half of Aussies had recently had COVID-19
At least 46% of the adult Australian population had acquired a COVID-19 infection with SARS-CoV-2 by June 2022
July 14, 2022
The Australian First Few “X” (FFX) research study for COVID-19
This study will help understand how emerging COVID-19 variants are transmitted within households
July 5, 2022
Triple vaccination seems to reduce the chance of long COVID – but we still need to prepare for a jump in cases
Let’s not repeat the mistakes of stigmatising and dismissing earlier post-infective syndromes like chronic fatigue syndrome
June 20, 2022
National antibody study confirms COVID-19 cases higher than reported
The Australian antibody survey was conducted in late February to early March 2022, approximately 6 weeks after the peak of the Omicron wave
June 16, 2022
APPRISED Issue 19 – June 2022
APPRISED – the newsletter of the APPRISE Centre of Research Excellence contains news about our response to infectious disease emergencies
June 14, 2022
How should an Australian ‘centre for disease control’ prepare us for the next pandemic?
Careful consideration and consultation is needed to understand how best to position an Australian CDC
June 8, 2022
More than 100 Australian kids have had multisystem inflammatory syndrome after COVID. What should parents watch for?
Inflammatory multisystem syndrome in children is a rare but potentially serious event following COVID infection
